| Lisa Marie Saturnino, MD | |
|
1665 Bonanza Dr., Park City, UT 84060-5127 | |
| (435) 649-7640 | |
| (435) 645-7668 |
| Full Name | Lisa Marie Saturnino |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 1665 Bonanza Dr., Park City, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336362490 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4956314-1205 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide, vincristine and prednisone (CVP) therapy improves progression-free survival in patients with stage III-IV indolent lymphoma, according to Howard S. Hochster, M.D. of NYU Langone Medical Center, lead author of a recent study published online ahead of print in the Journal of Clinical Oncology.
Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.
As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.
The development of treatment guidelines for illnesses such as diabetes is a complicated process.
A common treatment for anemia a deficiency in red blood cells (rbcs) caused by their insufficient production, excessive destruction, or excessive loss is administration of recombinant erythropoietin (Epo), a hormone that stimulates the production of rbc precursors by the bone marrow.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide, vincristine and prednisone (CVP) therapy improves progression-free survival in patients with stage III-IV indolent lymphoma, according to Howard S. Hochster, M.D. of NYU Langone Medical Center, lead author of a recent study published online ahead of print in the Journal of Clinical Oncology.
Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.
As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.
The development of treatment guidelines for illnesses such as diabetes is a complicated process.
A common treatment for anemia a deficiency in red blood cells (rbcs) caused by their insufficient production, excessive destruction, or excessive loss is administration of recombinant erythropoietin (Epo), a hormone that stimulates the production of rbc precursors by the bone marrow.
› Verified 8 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide, vincristine and prednisone (CVP) therapy improves progression-free survival in patients with stage III-IV indolent lymphoma, according to Howard S. Hochster, M.D. of NYU Langone Medical Center, lead author of a recent study published online ahead of print in the Journal of Clinical Oncology.
Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.
As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.
The development of treatment guidelines for illnesses such as diabetes is a complicated process.
A common treatment for anemia a deficiency in red blood cells (rbcs) caused by their insufficient production, excessive destruction, or excessive loss is administration of recombinant erythropoietin (Epo), a hormone that stimulates the production of rbc precursors by the bone marrow.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Marie Saturnino, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 491-6482 | Lisa Marie Saturnino, MD 1665 Bonanza Dr., Park City, UT 84060-5127 Ph: (435) 649-7640 |
News Archive
A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide, vincristine and prednisone (CVP) therapy improves progression-free survival in patients with stage III-IV indolent lymphoma, according to Howard S. Hochster, M.D. of NYU Langone Medical Center, lead author of a recent study published online ahead of print in the Journal of Clinical Oncology.
Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.
As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.
The development of treatment guidelines for illnesses such as diabetes is a complicated process.
A common treatment for anemia a deficiency in red blood cells (rbcs) caused by their insufficient production, excessive destruction, or excessive loss is administration of recombinant erythropoietin (Epo), a hormone that stimulates the production of rbc precursors by the bone marrow.
› Verified 8 days ago
Dr. Joseph Ferriter, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1665 Bonanza Dr, Park City, UT 84060 Phone: 435-649-7640 Fax: 435-649-1365 | |
John Joseph Hanrahan, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 510 Maple Dr, Park City, UT 84098 Phone: 435-714-0715 | |
Dr. Kenneth Alan Wolkoff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3065 Fawn Dr, Park City, UT 84098 Phone: 435-655-8212 | |
Brian J Rush, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2720 Homestead Rd, Ste 100, Park City, UT 84098 Phone: 435-940-9400 | |
Bradley Cris Cowley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Round Valley Dr, Park City, UT 84060 Phone: 435-658-7000 | |
Dr. Spenser Reed, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1790 Sun Peak Dr Ste A101, Park City, UT 84098 Phone: 435-645-0800 | |
Stefani Jane Day, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1665 Bonanza Dr, Park City, UT 84060 Phone: 435-649-7640 Fax: 435-645-7768 |